Rosacea Clinical Trials

[Guide]

"There are few validated methods of assessing improvement in rosacea, possibly due to the multiplicity of outcomes collected. Selective outcome reporting bias, defined as results-based selection of outcomes for publication, is a problem in many clinical trials and affects the conclusions of a significant proportion of systematic reviews." [1] Nevertheless, here are a number of resources for your consideration if you are contemplating entering a rosacea clinical trial. 

Resources

ClinicalTrials.gov
A service of the U.S. National Institutes of Health

NHS Clinical Trials

CenterWatch Clinical Trials

Multiple Nationwide Clinical Research Studies of an Investigational Gel for Severe ROSACEA are being conducted near you, Cutanea

ResearchTrials.org

IRF Centerwatch Clinical Trials

Autocruitment

Clinical Research Associates of Tidewater

ClinicalConnection

Wilmington Dermatology Center

Sinclair Dermatology

MayoClinic

Patient

SGS

Sterling Group Rosacea Research

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

End Notes

[1] Trials 201617:429, DOI: 10.1186/s13063-016-1554-3
Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey
Sanjana Iyengar, Paula R. Williamson, Jochen Schmitt, Lena Johannsen, Ian A. Maher, Joseph F. Sobanko, Todd V. Cartee, Daniel Schlessinger, Emily Poon and Murad Alam

 

[Guide]

Rosacea Trial in Austin, Texas

[Guide]

Stanford Secukinumab Clinical Trial (posted by David Pascoe)

Update June 15, 2020: 

"Patients treated with secukinumab for papulopustular rosacea saw significant improvements in quality of life and reduction of severity markers, according to a study presented at the American Academy of Dermatology virtual meeting."

Secukinumab demonstrates clinical improvement in rosacea patients, Healio

[Guide]

Center for Clinical Studies is looking for volunteers in a clinical trial who live near Houston, Texas. 

To learn more and to see if you qualify, call Center for Clinical Studies at 281-333- 2288, select option 2.

More contact details on their facebook page – Center for Clinical Studies.

[Guide]

Foamix is sponsoring a clinical trial through the Yardley Dermatology Associates in PA if you suffer from Phenotype 4. 

To see if you may qualify, call Yardley Dermatology Associates/Dr. Richard Fried at 215-579-6155 ext. 28 or visit www.yardleyderm.com for more information today.

[Guide]

FX2016-12: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, VEHICLE-CONTROLLED STUDY TO EVALUAGE THE SAFETY AND EFFICACY OF XXXXX 1.5% TOPICAL XXXXX COMPARED TO VEHICLE IN THE TREATMENT OF FACIAL PAPULOPUSTULAR ROSACEA. - Clinical Trial

Burke Pharmaceutical Research
3633 Central Ave., Suite I,
Hot Springs, Arkansas 71913
T: (501) 620-4449

Burke Pharmaceutical Research is now enrolling participants in a clinical study that offers medication and exams to those affected from rosacea at no cost.

To qualify for the program, the person must be 18 or older and have moderate to severe rosacea. Once qualified, they could receive a new foam medication and up to $300 compensation for their participation.

"Burke Pharmaceutical Research has spent the past 10 years growing from a small clinical trials unit into a unique research facility with an impressive record. Their dedicated staff is proud that the company, known for its 'small town' atmosphere, ranks consistently among the highest in the nation with its enrollment into clinical trials and patient retention rates," states the press release.

The office is located at 3633 Central Ave., Suite I, in Hot Springs, right next door to The Dermatology Clinic.

Anyone who would like to sign up for the rosacea study may call 501-620-4449.

If interested in learning more about the other programs that are available, view the full list online at http://www.burkepharmaceuticalresearch.com or http://www.facebook.com/burkeresearch.

The Sentinel-Record